search
Back to results

Endoscopic Management Of Iatrogenic Esophageal Perforation After Laparoscopic Upper Gastrointestinal Surgery

Primary Purpose

Iatrogenic Esophageal Perforation

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
endoscopic repair of iatrogenic esophageal perforation
Sponsored by
Zagazig University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Iatrogenic Esophageal Perforation focused on measuring stent, endoscopy , esophagus , iatrogenic injury

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients with Iatrogenic Esophageal Perforation after Laparoscopic Upper Gastrointestinal Surgery failued conservative meaures . patient with good general condition (ASA I&II). - Exclusion Criteria: We excluded patients who bad general condition (ASAIII&IV&V), respond to conservative measures.

Sites / Locations

  • Zagazig University Hospitals

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

group (1) endoscopic group

group (2) surgical group

Arm Description

For patients in EG, we began with assessment of the site & size of perforation . In this study, In this study, we used a fully covered stent (Mega stent, Taewoong Medical Industries, Gyeonggi-do, South Korea) ultra large and long (length: 24 cm, diameter: 36 mm) stent. We did not experience any complication with Mega stent, particularly migration, thanks to the design of Mega stent that fits well for the post-sleeve anatomy with reduction of migration. Concurrently, the interventional radiology team subcutaneously drained the intraperitoneal free fluid using 2 intra-peritoneal tubes that were placed under US guidance in the sub-hepatic region and in the pelvis

surgical repair of perforation after adequate drainage

Outcomes

Primary Outcome Measures

incidence of leak after the intervention
incidence of leak after the intervention

Secondary Outcome Measures

incidence of side effects of endoscopy
incidence of side effects of endoscopy

Full Information

First Posted
March 10, 2023
Last Updated
March 10, 2023
Sponsor
Zagazig University
search

1. Study Identification

Unique Protocol Identification Number
NCT05781022
Brief Title
Endoscopic Management Of Iatrogenic Esophageal Perforation After Laparoscopic Upper Gastrointestinal Surgery
Official Title
Endoscopic Management Of Iatrogenic Esophageal Perforation After Laparoscopic Upper Gastrointestinal Surgery : A Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
December 1, 2020 (Actual)
Primary Completion Date
July 1, 2022 (Actual)
Study Completion Date
August 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zagazig University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators included all patients who were presented to General Surgery Department with Iatrogenic Esophageal Perforation after Laparoscopic Upper Gastrointestinal Surgery at Zagazig University hospital between (December 2020 to August 2023).The sample size was calculated by using open Epi program depending on the following data ; confidence interval 95% , power of the test 80% , ratio of unexposed/ exposed 1 , the success rate of surgical repair versus endoscopic repair was 98 % versus 75% respectively. Odd ratio 16 , and risk ratio 1.3 , so the calculated sample size equal 84 patients divided into two equal groups. Included patients were randomized at a 1:1 ratio to "Endoscopic Group, EG" or "Surgical Group , SG" via the drawing of sealed envelopes containing computer-generated random numbers prepared by a third party before the start of the intervention.(simple random sample). Patients will be divided into 2 groups in accordance type of preoperative Therapy : Group 1: "Endoscopic Group, EG" included 42 patients. Group 2: "Surgical Group , SG" included 42 patients.
Detailed Description
A- Site of the study: The investigators included all patients who were presented to General Surgery Department with Iatrogenic Esophageal Perforation after Laparoscopic Upper Gastrointestinal Surgery at Zagazig University hospital between (December 2020 to August 2023). B- Sample size: The sample size was calculated by using open Epi program depending on the following data ; confidence interval 95% , power of the test 80% , ratio of unexposed/ exposed 1 , the success rate of surgical repair versus endoscopic repair was 98 % versus 75% respectively. Odd ratio 16 , and risk ratio 1.3 , so the calculated sample size equal 84 patients divided into two equal groups. c- Sample selection: Included patients were randomized at a 1:1 ratio to "Endoscopic Group, EG" or "Surgical Group , SG" via the drawing of sealed envelopes containing computer-generated random numbers prepared by a third party before the start of the intervention.(simple random sample). D- Subjects: Patients will be divided into 2 groups in accordance type of preoperative Therapy : Group 1: "Endoscopic Group, EG" included 42 patients. Group 2: "Surgical Group , SG" included 42 patients. Inclusion criteria: Patients with Iatrogenic Esophageal Perforation after Laparoscopic Upper Gastrointestinal Surgery , failued conservative meaures .patient with good general condition (ASA I&II). Exclusion criteria: We excluded patients who bad general condition (ASAIII&IV&V), , respond to conservative measures. E- Data collection (tools): All patients will subjected to the followings: patients were selected by randomization method, full history taking, Complete physical examination, laboratory investigations (complete blood picture, liver and kidney functions, coagulation profile, tumor marker tests, serum electrolytes), patients were assessed radio-logically by abdominal &chest x- ray , abdominal ultrasound, pelvic and abdominal CT, upper GI endoscopy. Study design (operational study): A. Type of the study : A randomized Controlled Trial. B. Steps of performance: Complete history taking. Clinical and laboratory results. Radiological results. Endoscopic management of Iatrogenic Esophageal Perforation after Laparoscopic Upper Gastrointestinal Surgery . Analysis of the results. Preparing conclusion and recommendation. C-Study techniques (procedure): For patients in EG, we began with assessment of the site & size of perforation . In this study, In this study, we used a fully covered stent (Mega stent, Taewoong Medical Industries, Gyeonggi-do, South Korea) ultra large and long (length: 24 cm, diameter: 36 mm) stent. We did not experience any complication with Mega stent, particularly migration, thanks to the design of Mega stent that fits well for the post-sleeve anatomy with reduction of migration. Concurrently, the interventional radiology team subcutaneously drained the intraperitoneal free fluid using 2 intra-peritoneal tubes that were placed under US guidance in the sub-hepatic region and in the pelvis. D-Outcomes: Primary and secondary outcomes were incidence of postoperative hospital stay and complications in each group during the 3-months follow-up period, respectively.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Iatrogenic Esophageal Perforation
Keywords
stent, endoscopy , esophagus , iatrogenic injury

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The investigators included all patients who were presented to General Surgery Department with Iatrogenic Esophageal Perforation after Laparoscopic Upper Gastrointestinal Surgery at Zagazig University hospital between (December 2020 to August 2023).Patients will be divided into 2 groups in accordance type of preoperative Therapy : Group 1: "Endoscopic Group, EG" included 42 patients. Group 2: "Surgical Group , SG" included 42 patients.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
84 (Actual)

8. Arms, Groups, and Interventions

Arm Title
group (1) endoscopic group
Arm Type
Active Comparator
Arm Description
For patients in EG, we began with assessment of the site & size of perforation . In this study, In this study, we used a fully covered stent (Mega stent, Taewoong Medical Industries, Gyeonggi-do, South Korea) ultra large and long (length: 24 cm, diameter: 36 mm) stent. We did not experience any complication with Mega stent, particularly migration, thanks to the design of Mega stent that fits well for the post-sleeve anatomy with reduction of migration. Concurrently, the interventional radiology team subcutaneously drained the intraperitoneal free fluid using 2 intra-peritoneal tubes that were placed under US guidance in the sub-hepatic region and in the pelvis
Arm Title
group (2) surgical group
Arm Type
No Intervention
Arm Description
surgical repair of perforation after adequate drainage
Intervention Type
Procedure
Intervention Name(s)
endoscopic repair of iatrogenic esophageal perforation
Intervention Description
For patients in EG, we began with assessment of the site & size of perforation . In this study, In this study, we used a fully covered stent (Mega stent, Taewoong Medical Industries, Gyeonggi-do, South Korea) ultra large and long (length: 24 cm, diameter: 36 mm) stent. We did not experience any complication with Mega stent, particularly migration, thanks to the design of Mega stent that fits well for the post-sleeve anatomy with reduction of migration. Concurrently, the interventional radiology team subcutaneously drained the intraperitoneal free fluid using 2 intra-peritoneal tubes that were placed under US guidance in the sub-hepatic region and in the pelvis
Primary Outcome Measure Information:
Title
incidence of leak after the intervention
Description
incidence of leak after the intervention
Time Frame
within one week after the procedure
Secondary Outcome Measure Information:
Title
incidence of side effects of endoscopy
Description
incidence of side effects of endoscopy
Time Frame
within one month after the surgery

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with Iatrogenic Esophageal Perforation after Laparoscopic Upper Gastrointestinal Surgery failued conservative meaures . patient with good general condition (ASA I&II). - Exclusion Criteria: We excluded patients who bad general condition (ASAIII&IV&V), respond to conservative measures.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Said Mohamed Negm, MD
Organizational Affiliation
ZAGAZIG UNIVERSITY HOSPITALS
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zagazig University Hospitals
City
Zagazig
State/Province
Sharquia
ZIP/Postal Code
1185
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Endoscopic Management Of Iatrogenic Esophageal Perforation After Laparoscopic Upper Gastrointestinal Surgery

We'll reach out to this number within 24 hrs